Table 1.
Experimental conditions used for gene expression studies in human astrocytes.
| label | treatment |
|---|---|
| 1 | control (con) |
| 2 | 3 h insulin (ins) |
| 3 | 4 days Lipofundin (lipids) |
| 4 | 4 days Lipofundin; 3 h insulin (lipids → ins) |
| 5 | 4 days Lipofundin; 3 days Lipofundin withdrawal (lipids → no lipids) |
| 6 | 4 days Lipofundin; 3 days Lipofundin withdrawal; 3 h insulin (lipids → no lipids → ins) |